Vasomedical Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc.

VASO 0.155

0.0%

12:18 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Fred Levine who wrote (862)	2/6/1998 4:45:00 PM
From: Fred Levine	Read Replies (2) of 1605

To all: Tony Peacock returned my call and we did discuss the comparisons. He specifically pointed out that as a publicly traded company, unlike Cardio, he was obliged to release information that would be available to all investors and could not engage in private discussions. There, obviously, are different constraints on public companies than private companies. He did emphasize what we had discussed previously, that VASO has outcome data, and that outcome data are necessary before any medical procedure is approved, and that he was not aware of any data from Cardio. In addition, he emphasized that EECP is a complete service in which VASO trains personnel as well as provides equipment. His tone was pleased the contued progress of VASO.. He also mentioned that 60 % of EECP treatments are used for strokes in China, but there were no data in this country of effectiveness. I think we should look at sales of each product rather than engage in a pissing contest. good investing---fred

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next